Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Sep 5;13(18):2864.
doi: 10.3390/diagnostics13182864.

Personalized Antiarrhythmic Therapy Using a Self-Managed Daily-ECG Device

Eugenio Mattei  1 , Stefano Lino  2 , Federica Censi  1 , Giovanni Calcagnini  1 , Leonardo Calò  2
Affiliations
Case Reports

Personalized Antiarrhythmic Therapy Using a Self-Managed Daily-ECG Device

Eugenio Mattei et al. Diagnostics (Basel). .

Abstract

A 50-year-old Caucasian man arrived at the emergency department presenting paucisymptomatic atrial fibrillation. Once discharged after the appropriate treatments, the patient continued to have paucisymptomatic episodes. For this reason, he was provided with the Cardionica device which made it possible to better investigate the type of arrhythmic episodes, in order to tailor his therapy and to finally restore a normal sinus rhythm in the patient.

Keywords: atrial fibrillation; daily ECG device.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interest/personal relationship which may be considered as potential competing interests: F.C., G.C. and E.M.: are inventors of one patent related to the submitted work and receive royalties. S.L. and L.C. are involved in a sponsored clinical trial of the Cardionica device.

Figures

Figure 1
Figure 1
The Cardionica device.
Figure 2
Figure 2
Report of the Cardionica device during the monitoring time, showing atrial fibrillation with high ventricular response.
Figure 3
Figure 3
Report of the Cardionica device after the tailoring of the therapy, showing normal sinus rhythm.
See this image and copyright information in PMC

References

    1. Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomström-Lundqvist C., Boriani G., Castella M., Dan G.A., Dilaveris P.E., et al. Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 2021;42:4194. doi: 10.1093/eurheartj/ehab648. Erratum in Eur. Heart J. 2021, 42, 373–498. - DOI - PubMed
    1. Drugs for atrial fibrillation. Med. Lett. Drugs Ther. 2019;61:137–144. - PubMed
    1. Zaman N., Naccarelli G., Foy A. A Comparison of Rate Control Agents for the Treatment of Atrial Fibrillation: Follow-Up Investigation of the AFFIRM Study. J. Cardiovasc. Pharmacol. Ther. 2021;26:328–334. doi: 10.1177/1074248420987451. - DOI - PubMed
    1. Mannhart D., Lischer M., Knecht S., du Fay de Lavallaz J., Strebel I., Serban T., Vögeli D., Schaer B., Osswald S., Mueller C., et al. Clinical Validation of 5 Direct-to-Consumer Wearable Smart Devices to Detect Atrial Fibrillation: BASEL Wearable Study. JACC Clin. Electrophysiol. 2023;9:232–242. doi: 10.1016/j.jacep.2022.09.011. - DOI - PubMed
    1. Hilbel T., Frey N. Review of current ECG consumer electronics (pros and cons) J. Electrocardiol. 2023;77:23–28. doi: 10.1016/j.jelectrocard.2022.11.010. - DOI - PubMed

Publication types

LinkOut - more resources